Skip to main content
. 2018 Jan 19;24(3):167–177. doi: 10.1111/cns.12786

Figure 2.

Figure 2

The prognostic performance of the six‐CpG signature on overall survival (A) in the pooled discovery cohorts (left) and each discovery set (right); and (B) in the pooled validation cohorts (left) and each validation set (right); P‐values from log‐rank test and meta‐analysis were indicated; RT, radiation; TMZ, temozolomide